Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Mike Ford
AstraZeneca
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
52
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Differences in Cardiovascular and Renal Outcomes Between Sodium Glucose Co-Transporter-2 and Dipeptidyl Peptidase-4 Inhibitors Among Type 2 Diabetes Patients: A Real-World, Retrospective Cohort Study
Number of pages: 41
Posted: 27 Jan 2021
Iskandar Idris
,
Ruiqi Zhang
,
Jil Billy Mamza
, Mike Ford,
Tamsin Morris
,
Amitava Banerjee
and
Kamlesh Khunti
Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, BioPharmaceuticals Medical, AstraZeneca - Medical and Scientific Affairs, AstraZeneca, BioPharmaceuticals Medical, AstraZeneca - Medical and Scientific Affairs, University College London - Institute of Health Informatics and University of Leicester - Leicester Diabetes Centre
Downloads
52
(1,041,696)
View PDF
Download
Abstract:
Feedback
